Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate
Prospective, Clinical Study of the Effect of Bariatric Surgery, Laparoscopic Sleeve Gastrectomy, on the Pharmacokinetics of Immunosuppressive Drugs in the Morbidly Obese, Kidney Transplant Candidate
Sponsor: Astellas Pharma Canada, Inc.
A observational or N/A phase clinical study on Obesity, Morbid and Transplant; Failure, Kidney, this trial is completed. The trial is conducted by Astellas Pharma Canada, Inc. and has accumulated 10 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jan 2020 — Nov 2020 [monthly]
Completed
Status: Unknown Status → Completed · Phase: PHASE4 → None
-
Oct 2018 — Jan 2020 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Astellas Pharma Canada, Inc.
- Canadian surgical research fund
- Maisonneuve-Rosemont Hospital
For direct contact, visit the study record on ClinicalTrials.gov .